Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36751 - 36775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CDK3	1018	downregulated	entinostat results in decreased expression of CDK3 mRNA	17q25.1	A21035
Entinostat	Investigational	CDKL2	8999	upregulated	entinostat results in increased expression of CDKL2 mRNA	4q21.1	A21037 A21035
Entinostat	Investigational	CDKN1A	1026	upregulated	entinostat results in increased expression of CDKN1A mRNA	6p21.2	A21035
Entinostat	Investigational	CDKN2B	1030	upregulated	entinostat results in increased expression of CDKN2B mRNA	9p21.3	A21035
Entinostat	Investigational	CDKN3	1033	upregulated	entinostat results in increased expression of CDKN3 mRNA	14q22.2	A21035
Entinostat	Investigational	CDYL	9425	upregulated	entinostat results in increased expression of CDYL mRNA	6p25.1	A21037
Entinostat	Investigational	CEACAM1	634	upregulated	entinostat results in increased expression of CEACAM1 mRNA	19q13.2	A21035
Entinostat	Investigational	CEBPB	1051	upregulated	entinostat results in increased expression of CEBPB mRNA	20q13.13	A21037
Entinostat	Investigational	CEBPZ	10153	upregulated	entinostat results in increased expression of CEBPZ mRNA	2p22.2	A21037
Entinostat	Investigational	CELF1	10658	downregulated	entinostat results in decreased expression of CELF1 mRNA	11p11.2	A21035
Entinostat	Investigational	CELF2	10659	downregulated	entinostat results in decreased expression of CELF2 mRNA	10p14	A21037
Entinostat	Investigational	CELF4	56853	downregulated	entinostat results in decreased expression of CELF4 mRNA	18q12.2	A21035
Entinostat	Investigational	CENPBD1	92806	upregulated	entinostat results in increased expression of CENPBD1 mRNA	16q24.3	A21035
Entinostat	Investigational	CENPV	201161	downregulated	entinostat results in decreased expression of CENPV mRNA	17p11.2	A21037 A21035
Entinostat	Investigational	CEP112	201134	downregulated	entinostat results in decreased expression of CEP112 mRNA	17q24.1	A21037
Entinostat	Investigational	CEP120	153241	downregulated	entinostat results in decreased expression of CEP120 mRNA	5q23.2	A21037
Entinostat	Investigational	CEP126	57562	upregulated	entinostat results in increased expression of CEP126 mRNA	11q22.1	A21035
Entinostat	Investigational	CEP41	95681	downregulated	entinostat results in decreased expression of CEP41 mRNA	7q32.2	A21037
Entinostat	Investigational	CEP70	80321	downregulated	entinostat results in decreased expression of CEP70 mRNA	3q22.3	A21037
Entinostat	Investigational	CEP85L	387119	upregulated	entinostat results in increased expression of CEP85L mRNA	6q22.31	A21037
Entinostat	Investigational	CES1	1066	upregulated	entinostat results in increased expression of CES1 mRNA	16q12.2	A21035
Entinostat	Investigational	CFAP44	55779	upregulated	entinostat results in increased expression of CFAP44 mRNA	3q13.2	A21035
Entinostat	Investigational	CFAP52	146845	upregulated	entinostat results in increased expression of CFAP52 mRNA	17p13.1	A21035
Entinostat	Investigational	CFD	1675	upregulated	entinostat results in increased expression of CFD mRNA	19p13.3	A21037 A21035
Entinostat	Investigational	CFLAR	8837	downregulated	entinostat results in decreased expression of CFLAR mRNA	2q33.1	A21037 A21035

Displaying entries 36751 - 36775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability